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Adoption of assisted dying is growing, but one argument against these policies is that 
they cause a suicide contagion, thus increasing suicides. Evidence for the assisted dying-
suicide link does not currently exist, and in general, research is scarce. I add to this body 
of literature to help stakeholders understand the consequences of such policies. I 
performed a time series study to determine how suicide rates changed in Belgium after 
assisted dying was introduced in 2002. The synthetic control method was chosen for the 
analysis, and additional European nations were included as placebos. The results show no 
change in suicide rates following the assisted dying policy change. A comparison of 
MSPE ratios with placebo countries also suggest statistical insignificance (p = 0.29). I 
conclude that there is no evidence that Belgium’s assisted dying policy is associated with 
a change in suicide rates or a suicide contagion.  
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Chapter 1. Introduction and Background 
Suicide contagion, formally known as the Werther effect, is a social phenomenon 
where suicide by a family member, peer group, or in the media can trigger suicides in 
susceptible (i.e., have pre-existing suicidal ideation) individuals (Gould & Lake, 2013). 
Several groups have raised concerns that assisted dying policies can act as a suicide 
contagion (Callahan, 1994; Jones & Paton, 2015; Kheriaty, 2015; Dunn, 2017; Francis, 
2017), which could lead to an increased number of suicides. Proponents of this 
connection argue that assisted dying sets a precedent that death is an acceptable solution 
for suffering, leading to a greater risk of suicide in a society that embraces the practise 
(Callahan, 1994; Dunn, 2017; Jones & Paton, 2015; Kheriaty, 2015). Evidence suggests 
that suicide contagion spreads via differential identification, meaning that victims must 
feel a sense of shared identity with the contagion’s source (Stack, 1990). This sense of 
shared identity can involve a number of characteristics, including similar health or 
socioeconomic problems. 
To my knowledge, a paper authored by Jones and Paton (2015) is the only study 
that attempts to find evidence of a link between assisted dying and suicide rates. Jones 
and Paton studied assisted dying policies in Oregon and Washington State, and they 
found no change in suicide rates after the introduction of these policies. However, a 
major limitation exists in this study: assisted dying policies in Oregon and Washington 
permit only patients with a terminal illness to access the procedure (Nicol & Tiedemann, 
2015). More specifically, the problem is that these states’ assisted dying policies would 
be unsuccessful in setting a precedent that death is an acceptable solution for suffering 
because the vast majority of suicidal individuals do not identify with the suffering of 
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terminal illness; instead, individuals with suicidal ideation largely identify with mental 
disorders (Hawton & van Heeringen, 2009). As it stands, the risk of a false negative is 
high in Jones and Paton’s study because the population in Oregon and Washington that is 
vulnerable to a suicide contagion is very small. Detection of a contagion, if it exists, 
would be much more likely if mental disorders were also eligible for assisted deaths. To 
build on the existing work, this study asks the following question: how do assisted dying 
policies, that also include assisted dying for mental disorders, affect the suicide rate of the 
general population?  
This paper will build on the Jones and Paton paper by using a form of time series 
analysis called the synthetic control method (Bouttell, Craig, Lewsey, Robinson, & 
Popham, 2018). Additionally, it will analyze data from jurisdictions that have permitted 
assisted dying for a broad range of disorders, including mental disorders. These 
jurisdictions include Belgium, the Netherlands, Luxembourg, and Switzerland (Nicol & 
Tiedemann, 2015). The results of this study should be informative for any jurisdiction 
that allows assisted dying, or those planning to expand the scope of their policies to allow 
assisted dying for persons with a broader range of health conditions.   
This thesis will begin with a background of the assisted dying policies in 
American states and European nations. A background on suicide contagion is also 
provided. Following the background material is a literature review of the existing 
evidence, along with details of the limitations in past evidence that need to be overcome 
to produce a more robust study. This paper then goes on to outline the methods that are 
used, followed by the results and a discussion.  
1.1 Background: Assisted Dying Policies 
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Different jurisdictions often use different terminology to describe assisted dying, 
and the distinctions are important because they signal differences in practise (Nicol & 
Tiedemann, 2015). Euthanasia generally refers to the act of someone else administering a 
lethal agent on behalf of the patient, such as when a physician uses an injection to induce 
death directly. Physician assisted suicide, sometimes called physician assisted death, 
defines the act where patients are prescribed a lethal medication but consume it 
themselves. Some jurisdictions explicitly outlaw one practice while allowing the other. 
This paper will not make a distinction between euthanasia and physician assisted suicide 
because several nations allow both; separating their individual contributions to a suicide 
contagion would not be possible or conducive to answering the research question. In this 
paper, both practises are referred to as “assisted dying.”   
1.1.1 Assisted dying in the United States. Oregon was the first American state to 
legislate assisted dying with the 1994 Death With Dignity Act (Nicol & Tiedemann, 
2015). The legislation took effect in 1997, decreeing that adult residents of Oregon, with 
a life expectancy of less than six months due to terminal disease, could qualify for an 
assisted death (Nicol & Tiedemann, 2015). Because of the 6-month rule, a large majority 
of assisted dying cases involve patients with end-stage cancer or ALS, making up 69% 
and 16% percent of all assisted deaths respectively (Nicol & Tiedemann, 2015). The state 
of Washington modeled its policy based on Oregon’s and has similar figures, with 70% 
of assisted deaths related to cancer and 13% with ALS (Nicol & Tiedemann, 2015). 
Washington’s bill took effect in 2009, making it the second state to legislate assisted 
dying.   
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The state of Vermont also based their assisted dying policy on Oregon’s. Because 
the legislation took effect in 2013, and because no health reports on assisted dying will be 
released until 2018, statistics are not available for this state (Nicol & Tiedemann, 2015). 
The state of Montana is a unique case. Rather than introducing legislation to legalize the 
practise, a state constitutional challenge found that prohibiting the right to die for 
competent and terminally ill adults violated human dignity, and that physicians can 
protect themselves from homicide charges by proving the patient’s consent(Nicol & 
Tiedemann, 2015). A lack of official framework is somewhat problematic as no statistics 
or other information can be garnered from the state, despite the decision having been 
made eight years ago (Nicol & Tiedemann, 2015).  
The past two years have seen four additional districts introduce legislation to 
allow assisted dying. Colorado, California, and Washington DC had their assisted dying 
laws take effect in 2016-2017, and Hawaii’s will take effect in 2019 (Nicol & 
Tiedemann, 2015). Because of how new these policies are, nopublished information is 
available to analyze.  
1.1.2 Assisted dying in Europe. European countries have the most permissive 
assisted dying laws in the world. The Netherlands has a long history in conducting the 
practise and is thus often the subject of research (Nicol & Tiedemann, 2015). Assisted 
dying legislation officially came into effect in 2002. However, the practise of assisted 
dying has existed for three decades prior to the implementation of the 2002 legislation 
(Rietjens, van der Maas, Onuwuteaka-Philipsen, van Delden, & van der Heide, 2009). 
The legitimacy of assisted dying in the Netherlands was first acknowledged in a 1973 
court case where a physician was prosecuted for helping her mother die; the sentence the 
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physician received was later suspended by the court. This incident sparked the gradual 
acceptance and utilization of assisted dying, but with no real oversight, and no clear-cut 
statement of decriminalization (Rietjens et al., 2009). During this period, assisted deaths 
were usually provided for terminally ill patients, but a court battle in 1994 oversaw the 
earliest case of assisted dying for grief that was solely psychological (Rietjens et al., 
2009). The Supreme Court of the Netherlands agreed that assisted dying could extend to 
cases where no physical illness is present, and the practise was not forbidden when 
assisted dying was legislated in 2002. Aside from the Netherlands and a select few 
European countries, no jurisdiction allows assisted dying for diseases that do not reduce 
life span (Nicol & Tiedemann, 2015).  
Belgium’s assisted dying legislation also took effect in 2002 and is also one of the 
select few jurisdictions that grant requests based solely on psychological grief (Nicol & 
Tiedemann, 2015). Unlike the Netherlands though, Belgian law explicitly states that 
mental disorders can qualify patients for an assisted death, whereas this clause is inferred 
through the wording of legislation in the Netherlands and previous court battles (Naudts 
et al., 2006). Also, unlike the Netherlands, Belgium did not have a history of assisted 
dying practise prior to the implementation of assisted dying legislation (Naudts et al., 
2006).  
Luxembourg’s assisted dying legislation came into effect in 2009 (Wirtz, 2017). It 
bears many similarities with Belgium’s framework, and Luxembourg also has no history 
of physicians providing assisted deaths prior to the legislation (Wirtz, 2017). Like the 
other European nations that allow assisted dying, mental disorders, or other disorders that 
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do not reduce the lifespan, do not exclude patients from receiving an assisted death 
(Wirtz, 2017).  
The situation in Switzerland is unique due to the length of time that the policy has 
been in effect. Assisted dying is not explicitly regulated in Switzerland, but is implied 
based on the wording of the 1942 Swiss Penal Code (Schwarzenegger & Summers, 
2005). The lack of regulation results in two unique approaches to the practise; the first 
allows non-physicians to provide an assisted death, and the second allows foreigners to 
travel to the country and receive an assisted death (Hurst, 2003). Switzerland has been 
involved in several high profile assisted dying cases because of this latter feature (Hurst, 
2003). The Netherlands, Belgium, and Luxembourg do not have residency requirements 
either, but it is necessary to have a working relationship with a physician in the country 
(Nicol & Tiedemann, 2015). Due to practical limitations, this essentially prohibits 
foreigners from travelling to the nation for an assisted death. 
1.2 Background: The Werther Effect 
The Werther effect is named after the protagonist of a book, published in 1774, 
called The Sorrows of Young Werther (Niederkrotenthaler, Herberth, & Sonneck, 2007). 
The book depicts a young man named Werther performing suicide by shooting himself 
with a pistol. Not long after the book’s publication, reports began to surface that an 
abnormal number of young men were found to have performed suicide using the same 
method that Werther used (Devitt, 2017). Whether this book truly caused a spike in 
suicides has not been firmly established, but researchers have substantial evidence of this 
phenomenon occurring in the modern era (Gould & Lake, 2013; Stack, 2003). This 
phenomenon is also known as suicide contagion because of how news of a notable  
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suicide spreads across a population and seems to invoke suicidal thoughts in some 
individuals as if it were an abstract infection (Cheng, Li, Silenzio, & Caine, 2014; Gould 
& Lake, 2013). Suicide contagion is the term favored in the literature that connects 
assisted dying with an increase in suicides, and that prompted my adoption of the term in 
this thesis.  
Just as young men in the late 18th century used a pistol to perform suicide, 
mirroring Werther’s actions in the novel, victims of modern-era suicide contagions also 
tend to use the same method as the contagion’s source (Cheng et al., 2014; Stack, 2003). 
It is believed that modern suicide contagions are most often the result of extensive media 
coverage of celebrity suicides (Jang, Sung, Park, & Jeon, 2016). It also appears that not 
just anyone can become the victim of a suicide contagion. Having pre-existing suicidal 
ideation or displaying various risk factors for suicide are traits that are seen in individuals 
that have become victims of suicide contagions (Gould, 2006; Cheng et al, 2007; Gould 
& Lake, 2013). Consequently, this means that there is a specific subset of the population 
that is vulnerable. One final characteristic of suicide contagion relevant to this study is 
the detection of evidence that a contagion had occurred. Past studies have shown that 
contagion-starting events, especially when it involves the suicide of a high-profile 
celebrity, can alter suicide rates at the aggregate or population level (Cheng et al., 2014). 
This implies that detecting evidence of a suicide contagion using population suicide rates 
is a feasible initiative. 
 1.2.1 Differential identification. The primary driver of the Werther effect is 
explained by a social theory known as differential identification (Stack, 2003). The 
application of this theory to the Werther effect suggests that a suicide contagion spreads 
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to victims that can in some way identify their personal traits or circumstances with the 
source of the contagion (Stack, 2003).  
 Identity characteristics that can result in the spread of a contagion include 
admiration, occupation, age, sex, and other demographic factors. (Gould, 2006; Jang et 
al., 2016). Circumstances such as divorce and other marital problems that already serve 
as risk factors for suicide can also result in the spread of a suicide contagion because 
victims begin to think of one person’s suicide as a solution to their own problems (Stack, 
1990; Olson, n.d.). Researchers have found evidence that a broad range of difficulties can 
cause differential identification and lead to suicide (Ministry of Health, 1999).  
 1.2.2 Assisted dying and suicide contagion. One argument that cautions against 
implementing assisted dying policies is that they can act as a suicide contagion (Callahan, 
1994; Dunn, 2017; Francis, 2017; Jones & Paton, 2015; Kheriaty, 2015). It is claimed 
that legalizing assisted dying normalizes, destigmatizes, and legitamizes death as a valid 
solution for suffering (Callahan, 1994; Dunn, 2017; Francis, 2017; Jones & Paton, 2015; 
Kheriaty, 2015). 
However, this connection may be limited by differential identification. A society 
that accepts assisted dying for terminal illness would at most convey that a hastened 
death is an acceptable solution to suffering when patients are already on the verge of 
death. If society rejects assisted dying for other forms of illness, such as mental disorders, 
then such behaviour would not be normalized, destigmatized, or legitimized; this sends a 
message that an early death is not an acceptable solution to the suffering brought on by 
that illness. Assuming that suicide contagion does occur, a consequence of differential 
identification is that different assisted dying policies will create contagions of differing 
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severity. If only a narrow range of medical circumstances are deemed acceptable for 
assisted dying, such as with American states and their 6-month prognosis rule, then a 
contagion will have very few victims to spread to. In such a scenario, a detectable 
increase in the population’s suicide rate may not occur, even if the hypothesis was true. 
This is because few people would have been exposed to the intervention. If suicide rates 
for only the vulnerable cohort were available, then detecting a contagion would be easy. 
Because suicide rates are collected for the entire population, test sensitivity becomes a 
problem. For this reason, a suicide contagion is most likely to be detected in jurisdictions 
that have implemented an assisted dying policy that includes a very broad range of 
medical conditions. It is especially crucial that mental disorders are included in the policy 
because they are the diseases that place patients at greatest risk for suicide, along with 
being attributed to the greatest number of suicides in high-income western nations 
(Hawton & van Heeringen, 2009). 
1.2.3 Limitations in the assisted dying-suicide contagion hypothesis. 
Proponents of the connection between assisted dying policy and suicide contagion base 
their statements on intuition derived from pre-existing literature about suicide contagion, 
such as studies of celebrity suicides. While there may be an intuitive relationship between 
assisted dying and suicide contagion, this connection is based on a number of implicit 
assumptions that are not supported by corroborating evidence.  
The first assumption is that assisted dying normalizes, destigmatizes, and 
legitimizes suicide. However, the differences between these two acts mean that they 
cannot be so easily equated. Assisted dying is a very medicalized procedure that involves 
consultation and coordination with healthcare practitioners and family members (CCA, 
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2018). Suicide is the opposite, carried out in isolation, and is not a decision that 
healthcare practitioners support. It is unclear if the general public would perceive these 
acts in a way that one legitimizes the other. Considering that health professions still 
denounce suicide, there is reason to doubt this assumption.  
Second, suicide contagion typically involves the replication of a suicide method. 
This phenomenon was thought to have occurred when the story of Young Werther 
allegedly caused a suicide contagion. It was reported that young male suicides were often 
performed with a pistol, just as Young Werther had done (Devitt, 2017). Modern 
evidence of this phenomenon shows that when a celebrity’s suicide method is reported, 
suicides in the general population that use that particular method suddenly increase (Jang, 
Sung, Park, & Jeon, 2016). In regard to assisted dying however, replicating the method of 
death is not feasible. Once again, this a highly medicalized procedure, and attaining 
easily ingestible drugs that can induce death is difficult. Replicating the method of death 
is especially difficult in jurisdictions that favor euthanasia because this requires a second 
person to directly administer a lethal agent.  
Third, suicide contagion relies on identification with the characteristics and/or 
circumstances of the individual who has died. It is unclear how this identification will 
occur in circumstances where the characteristics of individuals or the circumstances of 
their death are not made public. Even if they were, the general public relating their 
medical disorders to those that are approved for assisted deaths may not be enough to 
establish identification. Another characteristic of suicide contagion to consider is that 
young people, including adolescents, are most often affected; this is thought to be 
because they are more impressionable (Cheng et al., 2014). On the other hand, assisted 
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dying typically involves older adults with diseases of old age. (Nicol & Tiedemann, 
2015). The age groups that are most vulnerable to a suicide contagion are unlikely to 
relate to or feel inspired by the people and circumstances that are prolific in assisted 
dying. 
1.3 Considerations for Policy Development 
This thesis aims to help guide policy development by allowing stakeholders, such 
as physicians and legislators, to understand and weigh the benefits and harms of assisted 
dying policies.  
If evidence of a contagion is found, it would likely be at the forefront of any 
discussion that involved legalizing assisted dying for mental disorders. Furthermore, this 
discussion would have to extend to other incurable disorders, such as chronic physical 
disorders. This is because after mental disorders, chronic physical disorders are also 
strongly associated with suicide and suicidal ideation (Shen & Millet, 2012). Evidence 
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Chapter 2. Effects of Assisted Dying on Suicidality: A Literature Review  
The following review explores studies of assisted dying and suicide rates in 
Oregon and Washington, as well as a single study, cases, and anecdotes from Europe that 
relate assisted dying and suicidal ideation. 
2.0.1 Research strategy. The databases consulted for this literature review 
include PubMed, PsycINFO, and Social Science Citation Index (Web of Science Core 
Collection). Key words were structured with Boolean operators as ("suicide rate" OR 
suicidality OR "suicidal ideation") OR (“suicide contagion” OR “Werther effect” OR 
“copycat suicide”)AND (euthanasia OR "physician-assisted suicide" OR "assisted dying" 
OR "assisted death"). References used in the extracted articles, and articles that cited the 
extracted articles were also assessed for relevant material.  
The search results were limited to peer-reviewed journal articles and articles in 
English. The search range was limited to exclude articles prior to 1940 as this was 
approximately when the world’s first assisted dying policy came into effect. There were 
145 results from PubMed, 13,455 from PsycInfo, and 11,039 from Social Science 
Citation Index. Articles were included if they discussed how assisted dying, as a policy or 
as a medical procedure, affected suicides, suicidality, or a general desire to die. 
Additional material was found through a general Google search, but these items were 
limited to informal cases and anecdotes.  
 
 
2.1 How Suicidal Ideation is Affected by Assisted Dying 
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 There is an abundance of anecdotal evidence and cases where individuals explain 
how their suicidality is affected by assisted dying; this paper does not present an 
exhaustive list of this evidence, but it will go over some of the more prominent cases. 
Two particularly well-known cases come from two separate documentaries, with both 
featuring Belgian patients seeking assisted deaths due to psychiatric suffering. Road to 
Mercy is a documentary produced in association with the Canadian Broadcasting 
Corporation and features several different stories of patients seeking assisted deaths 
(Pequeneza, Bachinski, Bielz, & Khaskin, 2017). One of the stories in this documentary 
focuses on Amy De Schutter, a 29-year old female with a mental disorder that was 
declared treatment resistant after several years of failed therapies. Amy’s request for an 
assisted death is eventually approved, but in a twist, and despite unsuccessful past suicide 
attempts, she decides not to go through with the procedure, stating that the option being 
available is enough to comfort her (Pequeneza et al., 2017). In a very similar story 
published by The Economist (2015), 24 & Ready to Die is a film about a Belgian woman 
who is also losing her lengthy battle with mental illness. The film follows her as she goes 
through the various procedures required to receive an assisted death and ends with her 
deciding to cancel for the same reason as Amy.  
The decisions of Amy and Emily are not particularly uncommon, as physicians 
involved with providing assisted deaths relay similar anecdotes. Dr. Ellen Wiebe is 
Canada’s foremost practitioner of assisted dying, and while discussing Amy’s story, she 
describes seeing this phenomenon in her own patients (Martin, 2017). Other assisted 
dying practitioners claim to see this happen as well. EXIT is an organization in 
Switzerland that provides assisted deaths, and they claim that half their patients decide 
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not to go through with the procedure (EXIT, n.d.). It is important to note though that 
because Canada does not allow assisted dying for mental disorders, Dr. Wiebe’s patients 
generally do not suffer from them.  
 2.1.1 Study of Belgian patients. Additional evidence from Belgium comes from 
a study conducted by Thienpont et al. (2015). This study aimed to analyze the different 
patterns and characteristics of psychiatric patients that requested assisted deaths in 
Belgium. The retrospective study observed medical files of 100 consecutive applicants, 
from October 2007 through December 2011, who had requested an assisted death on the 
sole basis of their mental disorder. In total, 48 of the 100 applications were accepted. Of 
the 48 accepted applicants, only 35 went on to receive an assisted death. Of the remaining 
13, two performed suicide before the date of their procedure, while the other 11 cancelled 
their requests. The authors attempted to follow up with this latter group to understand 
why their requests were cancelled. Two applicants withdrew their requests due to strong 
family resistance, and one was deemed ineligible because the patient was imprisoned. 
The remaining eight stated that knowing they had the option was enough to give them 
peace of mind and continue living. Of the 52 applications that were not accepted, 38 had 
withdrawn before an accept/reject decision was reached. It is possible that some of these 
patients experienced feelings similar to the aforementioned eight patients, but the authors 
did not attempt to follow up with this group. It should be further noted that the follow-up 
was conducted at the end of 2012, and the patients were still alive at this point. The 
authors did not state at what approximate date each patient had their requests accepted, 
and no further follow-ups were carried out, so it is difficult to say how long these 
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individuals’ new-found peace of mind lasted. The authors also recognized that the small 
sample size of the study makes it difficult to generalize the findings.  
2.2 How Suicide Rates are Affected by Assisted Dying 
The only study that specifically examines the effect of assisted dying on 
suicidality was conducted by Jones and Patton (2015). Their study does not look at how 
individual suicidality is affected, but instead focuses on suicide rates across a population. 
Four American states were the subject of analysis: Oregon, Vermont, Washington, and 
Montana; only two of these, Oregon and Washington, could ultimately be analyzed 
because suicide rate and assisted dying data sets were not available in the other two 
states. Several factors known to influence or predict the suicide rate were controlled for: 
unemployment rate, per capita disposable income, black and Hispanic population 
compositions, percent of religious adherents, whether marijuana was medically or 
recreationally decriminalized, and if a 0.08 blood alcohol content law was in effect. In 
addition to comparing suicide rates before and after the policy was implemented, the two 
states with the intervention were also compared against the other American states without 
the policy.  
The study aimed to understand how suicide rates were affected by assisted dying, 
but also whether the average age at the time of suicide had increased. The primary 
method utilized in this study was a grouped logistic regression to determine the 
association between assisted dying legalization and suicide rates. Suicide rates were split 
into two categories for this study: total suicides [the combined rate of “traditional” 
suicides + legally provided assisted deaths] and non-assisted suicides [simply 
“traditional” suicides]. Though not made entirely clear, total suicides appear to have been 
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used to test an assumption that legalizing assisted dying results in a substitution effect 
where an assisted death takes the place of a suicide. Non-assisted suicides were used to 
test how the actual suicide rate changed in response to the assisted dying policies. The 
results of the study are adequately summarized with the following findings and their 
discussion:  
Controlling for state- and year-fixed effects, PAS is estimated to be associated 
with a 1.6% increase in nonassisted suicide rates; however, this is not statistically 
significant (95% CI -0.8% to 3.9%). The estimated effect is larger and statistically 
significant once other covariates are included (4.4%, 95% CI 1.9% [to] 6.8%). 
When we include state specific linear trends, however, the estimated increase is 
1.1% and not statistically significant (95% CI -2.5% to 4.8%)....The results 
pertaining to nonassisted suicide rates were equivocal. Some estimates suggested 
that PAS [physician-assisted suicide] also was associated with a significant 
increase in the rate of nonassisted suicide. When we included state-specific trends, 
however, the estimated association, although positive, was smaller and no longer 
statistically significant. (p. 603) 
 In other words, the suicide rate showed no statistically significant change when 
controlling for measured confounders.  
This study suffers from methodological limitations that necessitate further 
research on this topic. The chosen statistical model was an unorthodox approach to time 
series analysis, primarily because it appears to be a rarely used technique with possible 
validity issues, and no references were provided to indicate otherwise (Gertler, Martinez, 
Premand, Rawlings, & Vermeersch, 2011). The confounders that were controlled for are 
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another limitation that Jones and Paton acknowledged in their discussion. Francis (2017) 
evaluated the covariates that were used by Jones and Paton and found that marijuana 
criminal status and blood alcohol content laws were not very predictive of the suicide 
rate; additionally, some covariates highly predictive of the suicide rate, such as 
population density and divorce rates, were not included in the study.  
Another limitation that prevents detection of a suicide contagion is the policies 
that were the subject of analysis. As mentioned previously, assisted dying laws in Oregon 
and Washington are highly restrictive. This fact becomes a problem because suicide is 
overwhelmingly tied to mental disorders. As an example of this, Shen & Millet (2012) 
found that 70% of suicide victims in Oregon between 2003-2012 had a diagnosed 
psychiatric disorder, substance abuse problem, or depressed mood. In comparison, 24% 
of suicide victims had a physical health problem, with the majority involving chronic 
disorders. The fraction of patients with physical health problems that had a terminal 
illness with a 6-month prognosis would be fairly small. These aspects of American 
assisted dying laws are important because of the principle of differential identification. A 
very small portion of the Oregon and Washington populations would identify their 
circumstances with those of patients that are eligible for assisted dying, and so a similarly 
small fraction of the population is at risk of experiencing a suicide contagion, if any, from 
the assisted dying laws. Even if a suicide contagion did occur, it would be virtually 
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Chapter 3. Methods  
The purpose of this analysis was to determine whether the introduction of an 
assisted dying policy in the European regions was associated with a suicide contagion. 
While suicide contagion is not observed directly, suicide rates are used as a proxy 
outcome. As a time series analysis, this study observed pre-intervention suicide rates and 
analyzed how they changed in the post-intervention years. The synthetic control method 
helped control for confounders and other validity threats, which is detailed further in 
section 3.3.  
3.0.1 Ethics. This research project did not have a component requiring human 
participants. All data used in this study was taken from publicly available data sets, such 
as the OECD's online statistics portal. This study was approved by the University of 
Ontario Institute of Technology's research ethics board (REB File #14683).  
3.1 Variables 
As mentioned previously, suicide rates were the dependent variable of interest. 
The data sets for suicide rates were taken from the OECD's online statistics database 
(OECD, 2018e). The data was collected by national civil registration systems and curated 
in the World Health Organization’s (WHO) Mortality Database as crude suicide rates 
(suicide rates were age adjusted by the OECD). The WHO has attempted to standardize 
the classification of mortality between countries through its International Statistical 
Classification of Disease and Related Health Problems (WHO, n.d.). The 10th revision of 
this classification system has been in effect since 1993 and is still used today, thus 
providing consistency for the duration of the synthetic control analysis (WHO, n.d.). The 
data was available from the years 1960-2015, but some countries had missing data for 
25 
 
certain time periods. Although suicide rate data was available up until 2015, the missing 
data points restricted the use of data up until the year 2014 because of a conflict with the 
synthetic control model; this limitation is explained further in section 4.1. There is no 
strict requirement for how many years of data should be used for SCM, but Abadie, 
Diamond, & Hainmueller (2015) state that more time periods are preferable. Suicide rates 
were reported per 100,000 population.  
3.1.1 Predictor variables. I included predictor variables that were strongly 
correlated with suicide rates (Abadie, Diamond, & Hainmueller, 2010). These variables 
were derived from the literature.  
Andriessen, Krysinska, and Lester (2015) looked through time series data of the 
10 Belgian provinces to find suicide correlates for Belgium. Unemployment and divorce 
rates were found to be positively correlated with suicide, while population density was 
negatively correlated. Bernal et al. (2007) examined the risk factors for suicidality in the 
general population of Europe. They also found that divorce was significantly correlated 
with suicide, along with alcohol consumption, physician density, and healthcare 
expenditure. Maag (2008) reviewed numerous studies on the topic which reaffirmed these 
correlates and also found that life expectancy and higher education were correlated with 
suicide. We included predictors that were obtained from either the OECD or from 
Eurostats, the European Union’s official database of statistics. These predictor variables 
are defined as follows: 
• Crude divorce rate, per 1,000 population (Eurostats, 2018a). The data was 
collected by national statistics institutions and is based on official records. 
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• Highest education attained as a percentage of population aged 15-64 (Eurostats, 
2018b). Education levels were split into three categories: 0-2, 3-4, and 5-8. The 
definition of education levels is based on the International Standard Classification 
of Education. In this system, each number represents a level of education as 
follows:  
o Level 0 – Less than primary education 
o Level 1 – Primary education 
o Level 2 – Lower secondary education 
o Level 3 – Upper secondary education 
o Level 4 – Post-secondary non-tertiary education 
o Level 5 – Short-cycle tertiary education 
o Level 6 – Bachelor’s or equivalent level 
o Level 7 – Master’s or equivalent level 
o Level 8 – Doctoral or equivalent level 
Data on educational attainment was taken from a quarterly labour force sample 
survey. The surveys were defined and processed by Eurostats and conducted by 
national statistics institutions.  
• Population density per km2 (Eurostats, 2018c). 
• Unemployment as a percentage of the total population (Eurostats, 2018d). Data 
was taken from a quarterly labour force sample survey. The surveys were defined 
and processed by Eurostats and conducted by national statistics institutions. 
• Alcohol consumption in liters per capita (OECD, 2018a). Data on consumption 
was reported by each nation and is based on alcohol sales.  
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• Medical doctors per 1,000 population (OECD, 2018b).  
• Total health expenditure as a percentage of gross domestic product (OECD, 
2018c). Data was compiled by national statistics institutes and taken from 
organizational financial reports. 
• Life expectancy at birth in years (OECD, 2018d).  
For the most part, the existing literature showed that economic factors were more weakly 
correlated with suicide rates than sociodemographic factors.  It should also be noted that 
the variables discussed in this paper are not an exhaustive list of correlates, but instead 
are variables for which sufficient data exists for inclusion in this study. Factors such as 
mental health expenditure and recent mental illness are very predictive of the suicide rate, 
but data on these variables was often unavailable and thus excluded from the study. 
3.2 Country Selection 
Switzerland, Luxembourg, Netherlands, and Belgium are the countries of primary 
interest. However, there are certain criteria that must be met in order to be eligible for 
inclusion in the synthetic control analysis. Switzerland’s assisted dying policy is the 
oldest and took effect before the year 1960, which is the earliest year for which suicide 
rate data is available (Hurst & Mauron, 2003). Consequently, a pre-intervention analysis 
was not possible and so Switzerland was excluded. In contrast, Luxembourg has the most 
recent assisted dying policy of the four nations. Luxembourg drafted its assisted dying 
policy in 2008, and it came into effect in 2009 (Nicol & Tiedemann, 2015). This 
experiment was only able to make use of suicide rate data up until 2014, leaving just five 




The move to legalize assisted dying in the Netherlands was a very drawn out 
process, and assisted deaths were provided for over 30 years prior to the legislation. 
Rietjens, van der Maas, Onwuteaka-Philipsen, van Delden, & van der Heide (2009) found 
that 1.7% of all deaths were due to euthanasia in 1990, and it made up 1.7% of all deaths 
in 2005 as well, three years after legalization. These figures illustrate that the Netherlands 
was not suitable for study because the time between pre- and post-intervention periods 
was very long and imprecise. The legislation of the assisted dying policy did not serve as 
a point that caused adoption of assisted dying procedures due to the Netherland’s existing 
history with the practice.  
Like the Netherlands, assisted dying legislation came into effect in 2002 in 
Belgium (Nicole & Tiedemann, 2015). However, Belgium’s case was different in that 
there was no gray  area to conduct the practice prior to the legislation. The year 2002 
represents a point that separated assisted dying into well-defined before and after periods, 
making Belgium a suitable candidate for time series analysis (Vermeersch, 2002). The 
policy intervention year of 2002 also allowed numerous pre- and post-intervention time 
points. 
3.2.1 Donor countries. The donor countries had two purposes: first, the donor 
countries helped construct the synthetic control of the primary intervention group (i.e., a 
synthetic Belgium); this was done by analyzing data on suicide rates as well as the 
predictor variables for each donor country (Abadie et al., 2010). Second, the donor 
countries were used as placebo groups to perform placebo testing that helped ensure 
validity of the model and to determine statistical significance of the findings (Abadie et 
al., 2010). This process is detailed in section 3.3.1. The donor countries were required to 
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be characteristically similar to the intervention country in order to minimize differences 
across unmeasured confounders, but they should not have had the same intervention 
(Abadie et al. 2010).  
In order to utilize donor countries that were characteristically similar to Belgium, 
all other European nations with OECD data were included, with the exception of 
Switzerland and the Netherlands because they had already implemented assisted dying 
policies. Choosing European nations also increased the likelihood that exogenous factors 
that affected suicide rates were shared between Belgium and the donor countries. 
Luxembourg still served as a donor country because its policy was not introduced until 
much later. This narrowed the list of eligible donor countries to the following: Denmark, 
Czech Republic (CR), United Kingdom (UK), Ireland, France, Spain, Italy, Germany, 
Austria, Norway, Hungary, Poland, Slovakia, Sweden, Estonia, Finland, Greece, Iceland, 
Lithuania, Latvia, Portugal, Luxembourg, and Slovenia. 
3.3 The Synthetic Control Method 
 SCM is a technique first introduced by Abadie & Gardeazabal (2003) and was 
later refined by Abadie et al. (2010) with packages to support the use of SCM in various 
statistical software. SCM is a data driven procedure that produced an artificial control 
group, called the synthetic control, whose ultimate purpose was to represent a 
counterfactual of Belgium (the intervention group); in other words, the synthetic Belgium  
estimates what Belgium’s suicide rates would have looked like if the policy intervention 
in 2002 did not take place. If Belgium and the synthetic Belgium significantly diverged 
after 2002, the interpretation was that the policy caused a significant change in suicide 
rates. If Belgium and the synthetic Belgium both appeared to be approximately the same 
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after 2002, then the interpretation was that the policy did not have a meaningful effect on 
suicide rates.  
 SCM works with software that creates a synthetic control by analyzing data from 
Belgium’s suicide rates and predictor variables, and also the donor countries’ suicide 
rates and predictor variables. The software then attempts to find the best combination of 
this data, by assigning weights, that most accurately resembled Belgium’s suicide rates in 
the pre-intervention period only. The software then simulates the value of each data point 
in the post-intervention years by using the established combination of data and weights. 
Because the synthetic control only fits itself to pre-intervention data, it is void of any 
potential influence brought on by the policy change in the post-intervention periods. This 
effectively gives us an estimation of what Belgium would have looked like in the post-
intervention years had the policy change not occurred. The validity of this counterfactual 
is highly dependent on achieving a good fit between Belgium and the synthetic Belgium 
in the pre-intervention period. The accuracy of the fit can be determined qualitatively 
with a plot, or quantitatively through a calculation of the mean squared prediction error 
(MSPE), where a smaller MSPE signifies a better fit (Abadie et al., 2010).  
After conducting a review of studies that used SCM along with other time series 
methods, Bouttell, Craig, Lewsey, Robinson, and Popham (2018) determine that SCM 
performed at least as well as robust methods that have been traditionally used. The 
technique protects against a number of threats to internal validity, such as maturation, 
statistical regression, and history (only when the intervention country and donor countries 
are equally affected). The method is also capable of accounting for unobserved (only 
when intervention and placebo units are equally affected) and observed time-varying 
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confounders (Bouttell et al., 2018). This method was also chosen because it negated the 
necessity of the “parallel trends” assumption required for matching intervention groups 
with controls in methods such as difference-in-differences analysis (Bouttell et al., 2018). 
A suitable control that satisfied the parallel trends assumption was not available to pair 
with Belgium. 
3.3.1 Placebo and inference testing. Placebo tests are generally performed to 
help ensure the validity of a testing procedure. A placebo is an intervention that should 
not produce a positive test result, and thus can be used to determine if the testing method 
produces false positives. Placebos are also used to establish reference values to help 
determine if the real intervention had a meaningful effect on the outcome variable, and 
what the magnitude of that effect is. Abadie et al. (2010) described techniques for 
placebo testing with the SCM approach to fulfill both of these roles. This study used a 
procedure where SCM was applied one-by-one to each donor country using parameters 
identical to those initially used for Belgium. An SCM trial that shows suicide rates of a 
country and its synthetic control diverging after the policy change implies that the policy 
change had an effect. Because the donor countries did not implement the policy change, 
there should be no significant difference between the donor countries and their synthetic 
control. If type I errors do not appear in the placebo trials, it gives confidence that the 
statistical model is valid in its assessment of whether the policy change had an effect. On 
the other hand, the presence of type I errors would render the model as dubious.  
Upon completing the placebo trials, one way to detect type I errors was to visually 
compare the plot of Belgium, along with its synthetic control, against the plots produced 
by the donor countries as placebos. The entire plots can be compared against each other, 
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but a “gaps” plot was produced in this study which shows the deviation of a country’s 
suicide rates from its synthetic control’s suicide rates, where the synthetic control’s value 
is set to equal zero. Gaps plots were produced for Belgium and the donor countries and 
were presented in a figure that showed them overlaid on each other. For this stage of 
placebo testing, Abadie et al. (2010) recommended including only the results of placebo 
trials with pre-intervention MSPEs similar to those of the primary intervention group, 
which they defined as being no more than twice the MSPE of the primary intervention 
group. 
SCM is largely a visual method and thus does not rely on traditional significance 
testing, but it is still possible to establish quantitative reference values from the placebo 
trials and compare them with Belgium’s trial to determine if the policy change had a 
significant affect on suicide rates (Abadie et al., 2015). This process involved calculating 
the post-intervention MSPE between the real and synthetic values of each country’s 
suicide rates, and then dividing it by the respective pre-intervention MSPE to generate 
post-intervention to pre-intervention MSPE ratios (Abadie et al., 2015). In this stage of 
placebo testing, a larger MSPE ratio indicates that the real and synthetic values diverged 
by a larger magnitude. The MSPE ratios of the donor countries were used to establish 
reference values that the MSPE ratio of Belgium was compared against. A pseudo p-
value was then calculated to determine whether Belgium’s MSPE ratio was significantly 
greater than the ratios of the donors. If p < 0.05, then Belgium’s MSPE ratio  would have 
been significantly larger than that of the donors, indicating that the policy change affected 
Belgium’s suicide rates. Comparing MSPE ratios only tells us if the magnitude of change  
was significant and does not tell us whether the policy change caused suicide rates to 
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increase or decrease. A plot of Belgium and its synthetic control would need to be viewed 
to determine the direction of this relationship. A bar graph was produced to compare the 
MSPE ratio of each country.  
3.3.2 The 2008 Recession. Trends of suicide rates show that numerous European 
countries experienced increases in suicide rates after 2007, even when a downwards trend 
had been established for many years prior (OECD, 2018e). The sudden increases in 
suicides and analyses of the event suggest that the recession played a large role in raising 
suicide rates (Chang, Stuckler, Yip, & Gunnell, 2013). Though SCM is a very capable 
design, it struggles with exogenous factors that affected the countries included in this 
study differently. Evidence in the form of financial data indicates that the 2008 Recession 
is exactly one such exogenous factor, and a very significant one at that (Emmerson, 
2015). Consequently, a sensitivity analysis was performed to control for the recession by 
truncating the analysis at 2007, just prior to the start of the recession.  
3.4 Materials 
R was used to carry out the analysis. The package Synth was installed to access 
the required libraries. The command install.packages("Synth") was used to install this 
package (Abadie, Diamond, & Hainmueller, 2011). The code used for this analysis can be 
found in appendix A2.  
3.4.1 Commands for SCM. There were two R commands used to prepare data 
for the synthetic control that will be referred to in the Results section of this thesis The 
command time.predictors.prior described the predictor variables in the pre-intervention 
years that were analyzed to create the synthetic control. The data analyzed by this 
command, and the years for which it was analyzed, affect the pre-intervention fit. The 
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objective was to use the most time periods possible while minimizing MSPE (Abadie et 
al., 2010). The command time.optimize.ssr describes the pre-intervention years that were 
optimized when fitting the intervention group and the synthetic control to each other. 
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Chapter 4. Results 
Figure 4.1 shows suicide rates plotted against time in Belgium from the years 1984-2014. 
The solid line displays Belgium’s suicide rates for each calendar year. The vertical 
segmented line depicts the year of the policy change. Overall, suicide rates in Belgium 
fell from 24.6 in 1984 to 19.5 in 2002. Suicide rates continued to fall to 16.1 in 2014. 
4.1 Synthetic Control Analysis 
The implementation of the SCM analysis began with data preparation. Details 
about the following commands can be found in section 3.2.1. The command 
time.predictors.prior was given the value 1980-2001; 2001 was chosen because it is the 
last year before the intervention, and 1980 because it is a value that includes the greatest 
number of pre-intervention years while also yielding a pre-intervention MSPE smaller 
than any of the years prior to it. The command time.optimize.ssr was given the value 
1990-2001; 2001 again represents the last year before the intervention, and 1990 was 
Figure 4.1: Belgium’s suicide rates from 1984-2014. The intervention is labelled between the years 2001 






selected because missing dependent variable data for Germany prevented a time point 
prior to 1990 from being selected.  
Three donor countries were removed from the analysis because of missing 
dependent variable data. Poland was missing data in 1997 and 1998, Slovakia was 
missing data in 2006 and 2007, and Portugal was missing data from 2003-2005.   
Three predictor variables were removed from the final analysis because no data 
points exist in the pre-intervention years for one or more donor countries. Medical 
doctors was removed because data is missing for Ireland and Greece; unemployment was 
removed because data was missing for Iceland, Latvia, and Lithuania; and life expectancy 
was removed because data was missing for Latvia. The donor countries with the missing 
data could have been removed instead of removing medical doctors and unemployment, 
but it was found that including the donor countries was better able to minimize MSPE 
(sensitivity analyses of the alternatives are included in appendix A1). Removing Latvia in 
order to keep life expectancy reduced the MSPE, but by a very small amount; the 
resulting MSPE would be 0.65, just 0.01 less than the final MSPE achieved otherwise. 
Keeping Latvia was preferred so as to increase the statistical power of our significance 
tests.  
With these variables and paramters established, the synth command returned the 
most optimized MSPE of 0.66, indicating that a very good fit was achieved based on the 
the MSPE obtained in Abadie et al. (2010). Figure 4.2 shows the resulting plot of the 
synthetic Belgium with the real Belgium laid on top of it. The range of the plot begins at 
1990 because of missing outcome variable data from Germany prior to that, and ends at 
2014 because of missing outcome variable data in several placebo units beyond this time 
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point. Despite these limits, there is more than enough time charted to demonstrate the 
progression of the synthetic model. From Figure 4.2, we can see that there is a separation 
between the synthetic and real Belgiums at 2001, just before the policy change occurs; 
this was likely caused by difficulty modelling the pre-intervention data due to the large 
dip at 1999. Despite that, the two plots either got closer or maintained this approximate 
distance until 2006; this can be taken as evidence of the policy change having no effect 
during this time period. Even though the plots diverge a bit after 2006, they still manage 
to maintain a close distance and even converge again towards the end of the figure. There  
are two time points on the graph where the synthetic control and intervention group 
intersected each other: 2004 and 2013. These intersections further indicate that the real 
and synthetic Belgiums did not go on significantly different paths following the policy 
change. The time period during which the two plots showed a greater divergence also 




coincides with the 2008 Recession, a very important event that, as discussed in chapter 3, 
can cause some modelling difficulty. 
 Table 4.1 quantifies the difference between the suicide rates of the real and 
synthetic Belgiums for each time point in the plot. Aside from the year 1990, the largest 
discrepancy between the two Belgiums for the pre-intervention period was in 1999, an 
indication of how the dip at that time point skewed the synthetic model. While not 
significant from a policy standpoint, it does show that there is a degree of error in the 
model that is reflected in the resulting pre-intervention MSPE. 
 
 
Year 1990 1991 1992 1993 1994 1995 1996 1997 1998 
Value 1.35 -0.38 -0.34 0.85 -0.09 0.21 -1.26 0.49 -0.07 
 
Year 1999 2000 2001 2002 2003 2004 2005 2006 2007 
Value -1.32 -0.02 1.20 0.59 1.33 0.16 1.06 1.91 1.21 
 
Year 2008 2009 2010 2011 2012 2013 2014  
Value 1.51 1.37 1.74 2.33 2.30 -0.04 1.47 
Table 4.1: Differences between the suicide rates of the synthetic and real Belgiums at each time point in the 
plot.  








Belgium 2.20 12.01 7.29 334.25 45.17 33.14 21.67 
Synthetic 2.11 11.61 7.25 99.34 41.27 38.01 20.72 
Placebos 2.18 10.65 6.97 94.43 35.28 47.04 17.68 
Table 4.2: The mean values for each predictor variable in the pre-intervention time period. The first row of 
values represents the real Belgium, the second row represents the synthetic Belgium, and the third row 
represents the average of all placebo units. 
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Table 4.2 shows the average value of the predictor variables for each pre-
intervention time point. The table shows us that the analysis was able to create a synthetic 
Belgium that resembles the real Belgium fairly well for most of the predictor variables. 
This was aided by the fact that the means of the placebos also resemble Belgium quite 
well, a requirement for the synthetic analysis to be valid (Abadie et al., 2010). The one 
variable that did not capture Belgium at all was population density. However, a 
sensitivity analysis that involved running the synth command with this variable removed 
does not alter the pre-intervention fit, as the produced MSPE is still 0.66. An analysis of 
the relative contribution each predictor variable made to the construction of the synthetic 
Belgium is presented in Table 4.3. It is shown that the model did not utilize population 
density at all to construct the synthetic Belgium, explaining why its removal made no 
difference. Regardless, population density was kept in the model because it can still be 
used to make synthetic controls of the donor countries.  
 
4.2 Placebo Trials  
The next phase of the SCM analysis was the placebo trials. The donor countries removed 
in section 4.1 (Poland, Slovaki, and Portugal) were not included in this analysis either. In 
order to eliminate donor countries with a pre-intervenion MSPE twice that of Belgium’s 











0.017 0.095 0.314 0.000 0.100 0.083 0.390 
Table 4.3: The weight of each predictor variable when used by the model to construct the synthetic control. 
Density made no contribution while Education 5-8 was given the greatest weight. Note that predictors with 
synthetic values close to the real value, depicted in Table 4.2, do not necessarily have greater weights 
when creating the synthetic control.  
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(MSPE = 0.66), donors that had MSPEs greater than 1.32 in the placebo trials were 
excluded. This criterion means that France, Italy, UK, Ireland, Sweden, and Austria were 
included in the placebo trials while Germany, Spain, Czech Repiublic, Norway, 
Denmark, Finland, Luxembourg, Slovenia, Greece, Hungary, Lithuania, Latvia, Iceland, 
and Estonia were not. Results of the placebo trials can be found in Figure 4.3 in the form 
of a gaps plot. None of the donor countries showed significant divergence from each 
other and most of them converged to a value of zero towards the end of the plot, 
Figure 4.3: This gaps plot depicts the difference between each country’s real and synthetic suicide rate. The 
horizontal dashed line represents the synthetic control value, which has been set to equal zero, while the 
solid lines represent the deviation of each country’s real suicide rate from their respective synthetic 
controls. The vertical dashed line on the left is set between 2001 and 2002 when the policy change ocurred. 




providing evidence that the model has avoided type I errors. Belgium’s line was well 
within the limits of those that represent the donors, suggesting that the difference between 
the real Belgium and its synthetic control’s suicide rates was not meaningful.  
4.3 Significance Tests  
Figure 4.4 depicts the post-intervention to pre-intervention MSPE ratios of the 21 
countries, including Belgium. A higher value indicates that the suicide rates of the real 
country and the synthetic country are very different in the post-intervention period but 
were not so different in the pre-intervention period; therefore, a larger MSPE ratio 
implies that the policy change had a larger effect on the suicide rates of the analyzed 
group. The median value was 1.04 (Iceland), the mean was 3.07, and Belgium’s MSPE 
ratio was 3.34. The calculated pseudo p-value for Belgium was 0.24, indicating that the 
MSPE ratio was not statistically significant. In other words, the policy change had no 
meaningful effect on Belgium’s suicide rates, considering that the donors show a 

























Figure 4.4: The post-intervention to pre-intervention MSPE ratios of each country in the synthetic analysis 




4.4 Controlling for the 2008 Recession 
To control for the recession, the plot depicted in Figure 4.2 and the placebo trials 
depicted in Figure 4.3 would be the same, but with data points cut off after 2007. To 
avoid redundancy, these plots were not reproduced for this sensitivity analysis, but a label 
was included in Figure 4.3 due to the numerous lines. The same cannot be said for the 
MSPE ratios, and so a sensitivity analysis was performed to ensure that the recession had 
not meaningfully altered the results. Figure 4.5 shows the results of this analysis. In this 
trial, the median value was 0.86 (Ireland) and the mean was 1.64. Belgium’s MSPE ratio 
was 2.13, again having the 5th largest MSPE ratio and a pseudo p-value of 0.24, and thus, 
it was not statistically significant. Even when controlling for the 2008 Recession, the 
policy change did not have a meaningful impact on suicide rates given that the placebo 
trials showed similar MSPE ratios. 
 
Figure 4.5: The post-intervention to pre-intervention MSPE ratios of each country when controlling for the 




























While the order of countries in this analysis was different compared to the order 
presented in Figure 4.4, there was a general consistency between the two results. Table 
4.4 shows how the position of each country changed when going from the first trial of 
MSPE ratios to the second. Almost all countries had a change of five or less (five is 
approximately 1/4 of the total units), with just one country moving by a greater number. 
Two countries did not change position, and over half changed by no more than two 
positions. This consistency shows that synthetic model performed well, despite the 
challenge presented by the recession. In the next chapter, I discuss how the statistical 




Change -1 0 -3 +4 +1 +2 0 
Country Austria Belgium CR Denmark Estonia Finalnd France 
 
Change +2 +3 +2 -10 -4 -5 +5 
Country Germany Greece Hungary Iceland Ireland Italy Latvia 
 
Change +2 -2 +3 +5 +1 +1 -1 
Country Lithuania Luxembourg Norway Slovenia Spain Sweden UK 
Table 4.4: This table shows how each country change position amongst the entire pool of countries when 
comparing the second set of MSPE ratios to the first. A positive (+) notation indicates that the country has a 
larger MSPE ratio than other countries, relative to its position in the first trial. A negative (-) notation 




Abadie, A., Diamond, A., & Hainmueller, J. (2010). Synthetic control methods for  
comparative case studies: Estimating the effect of California’s tobacco control 
















Chapter 5. Discussion and Conclusion 
The time range of analysis was limited to 1990-2014, or 25 years, but this was 
sufficient to understand how the synthetic Belgium differed from the real Belgium. 
Boutell, Craig, Lewsey, Robinson, and Popham (2018) state that there is currently no 
reference point to determine what a good pre-intervention fit is, but Abadie, Diamond, 
and Hainmueller (2010) achieve a pre-intervention MSPE of approximately 3.0 in their 
analysis and consider it to be a good fit. Using this as a benchmark, the 0.66 MSPE 
achieved in this study is an excellent result. The pre-intervention fit is crucial for validity, 
so this result brings confidence to the findings.  
 Even before the policy change took effect, the synthetic and real Belgiums were 
slightly separated from each other. The two models were very similar in the year 2000, 
but separated from each other in 2001. This sudden change in level just prior to the onset 
of the intervention is a known occurrence when performing time-series analyses 
(Wagner, Soumerai, Zhang, & Ross‐Degnan, 2002). The effect is attributed to the 
“anticipatory demand” that occurs when the public suspects or knows that a policy 
change is coming. As the public shifts their behaviour in anticipation of the policy 
change, the outcome variable will suddenly increase or decrease (Wagner et al., 2002). 
This effect is dependent on whether the policy has an association with the outcome 
variable, but if so, the variable will change before the policy change is actually legislated 
or takes effect. I determine that this explanation is not suited to this case because the real 
suicide rate in 2000 and 2001 is the same, meaning the anticipatory demand effect could 
not have occurred – it is the synthetic suicide rate that experiences the change in the level. 
I conclude that this discrepancy is not evidence of the policy change causing a suicide 
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contagion via anticipation effect. The discrepancy is likely due to a small degree of error 
in the model caused by the wild data point in the year 1999. SCM models the outcome 
variable over many time periods to determine long-term trends, and the study also 
achieved an overall strong pre-intervention fit, so this error ultimately does not 
complicate the findings.  
Even though the synthetic model was slightly skewed going into the post-
intervention period, the main SCM output (Figure 4.2) shows that the synthetic control 
was not all that different from the real Belgium because they remain nearly parallel for 
the duration of the analysis. This is most obvious from 2002-2005, where the difference 
between the two Belgiums is always smaller than the difference at 2001, a pre-
intervention year. This gap becomes larger at 2006, and then even larger at two time 
points during the recession period. In an ideal scenario, any impact the recession had on 
suicide rates in Belgium would have equally happened in the other European countries. 
Because European countries are being used as donors, this ideal scenario would mitigate 
confounding caused by the recession. Reality is different however, and each country 
experienced the recession in different ways. This asymmetry means that confounding is 
not entirely controlled for by the SCM, thus causing this time period to be a modelling 
challenge. Despite this, the synthetic and real Belgiums do not wildly differ, with the 
greatest separation occurring in 2011 by a value of 2.33. Instead of seeing a consistent 
trend of Belgium and the control diverging from each other over time, the two plots 
instead converged and intersected each other in 2013. Because the two plots remain very 
close to each other, are nearly parallel, and fail to show divergence, I interpret the 
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synthetic control as evidence that the assisted dying policy change did not affect 
Belgium’s suicide rates.  
When again looking at the main output but cutting off values after 2007, I 
effectively performed a sensitivity analysis that controlled for the recession. As 
mentioned above, the period from 2002-2005 shows that the synthetic and real Belgiums 
stay very close to each other, and the separation eventually becomes larger in 2006, but 
not in 2007. Given that there are only have six time points to examine in the sensitivity 
analysis, it is difficult to say that the slight divergence shown is evidence of the synthetic 
and real Belgiums trending apart from each other. With so few time points, the 
divergence would need to be more substantial to consider this as evidence of the policy 
change having had an effect on suicide rates. Ergo, I conclude that the sensitivity analysis 
of the main output which controlled for the 2008 Recession does not show evidence that 
the policy change had an effect on Belgium’s suicide rates, but confidence in this result is 
reduced because of the limited time points available to analyze.  
 In total, seven countries had placebo trials conducted and were included in the 
gaps plot (Figure 4.3). The gaps plot has the synthetic model set to equal zero, so the 
lines shown belong to the real countries and how the real suicide rates deviate from the 
synthetic suicide rates at each time point. None of the countries show a deviation greater 
than three. Most countries show a similar pattern of diverging and reaching their greatest 
degree of separation from the synthetic model in the years associated with the recession. 
After reaching a peak, the synthetic and real models converge towards the end of the final 
years of the figure. I interpret the placebo analysis as not showing type I errors because 
the real and synthetic models show no obvious sign of diverging from each other. The 
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placebo trials also provide evidence that Belgium’s suicide rates were not significantly 
altered by the policy change because the deviation from its synthetic control is very 
similar to the deviation shown by the donor countries. The sensitivity analysis involving 
the gaps plot is less clear in its interpretation. The discrepancy between Belgium and its 
synthetic control is nearly the same in 2001, 2003, and 2007, giving the plot an 
appearance that is almost parallel to the synthetic control. I interpret this as evidence that 
the policy change did not affect suicide rates. However, it is not so clear as to whether 
one of the placebo trials resulted in a type I error. The donor country at the very top 
appears to be significantly diverging from its synthetic control. This trend eventually 
reverses after 2008, but it is difficult to state that this would have also happened in the 
absence of the recession.  
 The first two outputs in this study are very dependent on visuals to present and 
interpret the results. This demands some degree of subjectivity. In contrast, the final test 
involving post-intervention to pre-intervention MSPE ratios is entirely quantitative and is 
specifically meant to help determine if the effect the policy change had on Belgium’s 
suicide rates was significant. Belgium’s MSPE ratio was the 5th largest, which is well 
within the placebo ranges established by the donor countries. As per the explanation 
provided by Abadie, Diamond, and Hainmueller (2015), if one were to choose a country 
at random in this analysis, there is a 24% chance of picking a country with an MSPE ratio 
equal to or greater than Belgium’s. This high probability shows that Belgium’s MSPE 
ratio is not a statistical anomaly. This test was performed again to control for the 
recession and the result was the same.  
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 The three outputs produced a consistent result that suggests suicides rates were 
not meaningfully altered by the intervention. The same is true for the three sensitivity 
analyses, though the analysis involving the placebo trials is less clear. I conclude that 
Belgium’s assisted dying policy did not have an impact on the nation’s suicide rates. This 
conclusion is the same that Jones and Paton (2015) ultimately reached in their study for 
Oregon and Washington. Because suicide rates were used as a way to estimate the 
presence of a suicide contagion, I also conclude that this study does not show evidence 
that a suicide contagion occurred.   
5.1 Strengths and Limitations 
 The use of the SCM is a major strength of this study. This procedure is a powerful 
study design because of its data driven nature and because it is essentially a form of 
machine learning. The ability to account for observable and unobservable confounders 
while also protecting against a range of other validity threats provides ample reason to be 
confident in the results. The small pre-intervention MSPE, the similarity between 
Belgium and the synthetic control in terms of predictor variables, and the lack of type I 
errors further reinforce validity. Another strength of the study is that Belgium was an 
ideal subject for this investigation. In addition to meeting all of the inclusion criteria, 
Belgium is considered to have the world’s most permissive assisted dying policy (PBS 
News Hour, 2015; Nicol & Tiedemann, 2015); this trait makes Belgium the most likely 
jurisdiction to experience a suicide contagion, and therefore the best jurisdiction for 
detecting this phenomenon. If Belgium with its extreme assisted dying policy did not 
experience a suicide contagion, then it is all the more likely that other jurisdictions have 
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also not experienced it, and future jurisdictions that legislate assisted dying will not 
either. 
 The data driven nature of this study is certainly one of its strengths, but there are 
several data quality issues that make it a weakness as well. Certain variables highly 
predictive of the suicide rate, such as mental health funding and serious mental illness in 
the past year, were typically not available for Belgium’s pre-intervention years and were 
thus excluded from the study. Additionally, some predictors which were at first included 
in the model later had to be removed because of missing data for placebo units. Overall, 
the missing data limited the number of confounders that were directly controlled for. 
Even though the donor countries allow unmeasured confounders to be controlled for, 
confounders that asymmetrically affected the included countries could not be entirely 
controlled. The models were also limited by missing suicide rate data in Germany, which 
prevented optimisation and plotting of time points prior to 1990. Even if Germany was 
excluded from the study, several other nations also had missing data in the 80’s; for each 
nation removed, only two or three additional years would be gained for optimisation, thus 
making this a vain effort with little positive effect. The number of donor groups available 
for use in this study is another data limitation. Three nations had to be excluded because 
of missing dependent variable data, but there are many more European nations that were 
never considered because data was not available in the OECD database. Increasing the 
number of donor groups would have led to a more powerful significance test by 
providing more opportunity to understand what sort of results should be expected in 
regions that did not have the policy intervention. Finally, the fact that only Belgium could 
be tested as a treated group represents a significant sample size limitation. While 
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Belgium’s permissive assisted dying policy helps to generalize the findings, the sample 
size limitation hinders it greatly. This limitation exemplifies the overall difficulty in 
studying the relationship between suicide rates and assisted dying, a conclusion that Jones 
and Paton came to as well.  
5.2 Possible Explanations for the Results 
 The hypothesis of a relationship between assisted dying and suicide contagion is 
intuitively based on what is known about suicide contagion when it occurs in other 
scenarios, such as with celebrity suicides. Considering this, what are some possible 
explanations for why suicide rates were not found to have been altered in this study? The 
first explanation to explore is that the hypothesis is fundamentally incorrect because of 
important distinctions between assisted dying and suicide. For instance, Francis (2017) 
points out that suicide contagion often involves victims replicating the suicide method 
used by the contagion’s source. Assisted deaths are wrapped in medical procedures and 
often involve planning and the presence of family and friends. This stands in contrast to 
suicide which must be carried out in isolation, is dissuaded by healthcare practitioners, 
and generally retains a stigma. The exact method of death cannot be recreated in suicide, 
and the optics of the entire process is different as well. Belgian law also requires that 
mental disorders must be treatment resistant to be considered for an assisted death. This 
process can involve years of consultations to exhaust therapy and pharmaceutical options 
before treatment resistance is reached (Boer, 2017). These distinctions may cause a 
disconnect between suicidal individuals and the situations that assisted dying patients 
find themselves in, thus interfering with their ability to identify with the concept of 
assisted dying.  
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 Further building on the possibility that the hypothesis is fundamentally invalid, 
there may also be a disconnect between individuals susceptible to a suicide contagion and 
the concept of assisted dying because of age. Some research studies have suggested that 
adolescents are the most susceptible to a suicide contagion (Cheng, Li, Silenzio, & Caine, 
2014). On the other hand, assisted dying is only relevant to older age groups because of 
direct age restrictions and because the diseases which are eligible naturally present 
themselves in older age groups. Until a jurisdiction and the society therein accepts 
assisted dying for all adolescents, a suicide contagion is not expected to be seen while 
working with this explanation.  
 Another explanation to consider is that contagion victims are not attempting 
suicide but are instead motivated to receive an assisted death themselves. If this is the 
case, we might expect to see a decrease in the number of suicides. If this were the case, 
the contagion may not be detectable in the suicide rate, but there may be evidence of it in 
assisted dying statistics. However, this is unlikely to be the case since the number of 
assisted deaths is small relative to the number of suicides. For instance, assisted deaths 
for psychiatric disorders would make up just 1.6% of suicides in Belgium in 2012. 
Furthermore, there were zero assisted deaths based solely on psychiatric disorders in 
2005 and 2007. Unfortunately, information on the number of applicants for medically 
assisted death is not collected. In addition, because this study analyzed population-level 
suicide rates, we observed only net effects. It is possible that some individuals 
experienced reduced suicide ideation after the implementation of assisted dying policy 
because an alternative option became available, while others experienced increased 
suicide ideation due to a suicide contagion effect. The net of these two effects may have 
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resulted in zero change. Thus, the results of this study suggest that assisted dying policy 
did not result in a meaningful increase in overall suicide rates at the population-level. 
However, this finding may not translate to the individual-level.  
5.3 Policy Implications 
The analysis presented above used time-series data to determine whether the 
introduction of assisted dying policies in Belgium generated a suicide contagion that 
increased suicide rates. The findings of this analysis suggest that there is no reason to 
believe a suicide contagion occurred at the population-level.  
This conclusion is useful in terms of guiding policy formation. First, the four 
nations that presently allow assisted dying for mental disorders, which includes Belgium, 
have seen mixed reception from residents towards this policy (Council of Canadian 
Academies [CCA], 2018). Part of this concern is around the possibility of a suicide 
contagion. However, this study does not support these concerns.  
Second, jurisdictions that are considering the implementation of an assisted dying 
policy or those who plan to expand the scope of their policies may benefit from these 
findings, which may assuage concerns about a possible suicide contagion effect.  
To our knowledge, Canada is the only country actively looking to make 
significant modifications to its assisted dying policy. Recently, a panel of experts released 
a report that was intended to give the Canadian Parliament information about three 
possible ways to expand assisted dying, and allowing assisted dying for mental disorders 
is one of those possibilities (CCA, 2018). In their report, the expert panel raised a 
discussion on the association between legalizing assisted dying and general suicide rates. 
The expert panel reviewed the findings of Jones and Paton’s study, but noted that 
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research on the association between assisted dying, where mental disorders are involved, 
and suicide rates does not exist. This knowledge gap brought forth by the expert panel is 
addressed through our study, and it may help inform the panel to confidently state that no 
reason currently exists to believe that expanding Canada’s assisted dying policy will 
increase suicide rates. Canada is also reviewing the expansion of assisted dying for 
mature minors. The expert panel raised a concern that this policy would normalize 
suicide among youth (i.e. a suicide contagion), and that the risk is greater if the individual 
has a mental disorder. This knowledge gap is partially addressed by this study; I do not 
perform a detailed analysis of how different age groups have their suicide rates 
influenced by the policy change, but overall, the findings indicate that suicide is not 
normalized for mentally ill individuals in the general population when individuals in 
similar circumstances access assisted dying. More research is needed to confidently state 
how different age groups, including youth, have their suicide risk affected by assisted 
dying policies. Performing such a study with the synthetic control is ideal but unlikely to 
be feasible because of the large quantity of data required. Across many different 
variables, data on specific age groups is not collected or collection has begun very 
recently, thus requiring more time to pass before a valid study can be conducted.   
Several American states have also dealt with the question of suicide contagion 
brought on by assisted dying policies. America has seen a much greater prevalence of this 
discussion relative to other nations. The argument that assisted dying can increase suicide 
rates has been disseminated through media and also through direct legislative testimonies 
despite there being no evidence yet to support the claim (Gordon Conwell Theological 
Seminary, 2017; Francis, 2017; Kheriaty, 2015). States that have already created their 
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policies and states that are currently exploring the option to legislate assisted dying have 
all seen this discussion appear at some point. Interestingly, the suicide contagion 
discourse seems to be more common in America even though it is home to the most 
restrictive assisted dying policies in the world. Whether this is actually true has not been 
studied, but if so, understanding why Americans have so fervently adopted this attitude 
may be worth looking into.  
5.4 Conclusion 
 Using the synthetic control method, I was unable to find evidence that the 
legislative adoption of assisted dying affected suicide rates in Belgium. Suicide rates 
were used as an indirect measure of suicide contagion, and thus I do not find evidence of 
suicide contagion. The different tests performed as part of the synthetic control analysis 
were fairly consistent in determining this result. This conclusion is also similar to that of 
the sole previous study that examined this topic. However, this study is able to add to the 
literature by using the SCM and focusing on a jurisdiction that allowed assisted dying for 
mental disorders, as well as a broad range of terminal and chronic diseases.  
 Even though the assisted dying-suicide contagion hypothesis seems to make 
intuitive sense at first glance, the numerous claims that assisted dying can cause a suicide 
contagion have been made without supporting evidence. For stakeholders that may feel 
confused about these claims, especially if they were to feel morally complicit in 
associated suicides, this study brings much needed clarity.   
 Conducting further studies on this topic is presently a difficult challenge, and it 
would be especially difficult to construct one using valid methodology. However, with 
many jurisdictions having legalized assisted dying, and many more to come, the pool of 
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subjects available to study will increase. Time is a major obstacle to this, but studies that 
more directly measure suicide contagion at the individual level can be executed right 
now. What makes this such an appealing topic to follow up on is the reports of how 
individuals with suicidal ideation can experience a reduction in symptoms when they 
have access to assisted dying. There are many questions regarding this that can be 
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Appendix A.  
A1. MSPE sensitivity analyses.  
The best optimized synthetic control analysis returned an MSPE of 0.66. Using 
that as a baseline and then removing Latvia, Lithuania, and Iceland in order to introduce 
unemployment into the analysis results in an MSPE of 2.14. Returning back to baseline 
and then removing Greece and Ireland to introduce medical doctors to the analysis results 
in an MSPE of 0.68. Thus, removing the control variables to include more predictor 
variables is unfavorable for the statistical model.  
A2. R code for the synthetic control analysis.  





#resolves: "Error in dataprep(foo = data, predictors = c("divorce", "alcohol", "life", : unit.variable not 
found as numeric variable in foo." 
 





dataprep.out <-    
              dataprep(foo = data1, 
                       predictors = c("divorce", "alcohol", "expenditure", "density", "edu1", "edu2", "edu3") , 
                       predictors.op = "mean" , 
                       time.predictors.prior = 1980:2001, 
                       dependent = "suicide", 
                       unit.variable = "regionno", 
                       unit.names.variable = "regionname", 
                       time.variable = "year", 
                       treatment.identifier = 2, 
                       controls.identifier = c(1,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,21,23,24), 
                       time.optimize.ssr = 1990:2001, 
                       time.plot = 1990:2014 





 synth.out <- synth(data.prep.obj = dataprep.out, 
                    method = "BFGS") 
  
 
#dependent variable discrepancy between actual and synthetic, 1993-2007 
 
 gaps <- dataprep.out$Y1plot - (dataprep.out$Y0plot %*% synth.out$solution.w) 





synth.tables <- synth.tab(dataprep.res = dataprep.out, 
                           synth.res = synth.out 
                           ) 
  
 

















 path.plot(synth.res = synth.out, 
           dataprep.res = dataprep.out, 
           Ylab = "suicides (per 100,000)", 
           Xlab = "year", 
           Ylim = c(5,30), 
           Legend = c("Belgium","Synthetic "), 
           Legend.position = "bottomleft" 
           ) 
  
#produce gaps plot 
 
 gaps.plot(synth.res = synth.out, 
           dataprep.res = dataprep.out,  
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           Ylab = "suicides (per 100,000)", 
           Xlab = "year", 
           Ylim = c(-5,5), 
           Main = NA 
           )  
 
 
 
 
 
